Le Lézard
Classified in: Covid-19 virus
Subjects: Survey, Economic News/Analysis

Best's Market Segment Report: AM Best Maintains Negative Outlook on Japan Life Insurance Market


AM Best is maintaining its negative market segment outlook on Japan's life insurance segment, citing the social and economic impacts of the COVID-19 pandemic on life insurers' top-line growth and significantly dampened investment income due to low interest rates.

A new Best's Market Segment Report, "Market Segment Outlook: Japan Life Insurance," notes that Japan continues to face ongoing pressure domestically and abroad from the economic fallout from the COVID-19 pandemic. Consequently, AM Best's negative outlook primarily reflects an anticipation of headwinds for the near-term operating performance metrics of Japan life insurers. In AM Best's view, the current and forecast macroeconomic conditions are likely to suppress top-line growth and profitability of most domestic life insurance companies. However, AM Best notes that most life insurers maintain very strong risk-adjusted capitalisation, and are expected to be able to withstand the potential impact on capital changes that may result from volatility in the global financial markets.

According to the report, domestic life insurance sales in Japan recovered gradually over the second half of fiscal year 2020-2021, on the back of a slow but steady resumption of sales activity, and the implementation of new business strategies. These new initiatives include the increased use of online and digital tools to mitigate the impact of reduced face-to-face sales activity, as well as the promotion of new product features addressing heightened and emerging customer needs.

However, Japan's real GDP for the period April to June 2021 is projected to decrease for a second consecutive quarter, mainly due to an extension of the country's state of emergency over the COVID-19 pandemic. Downward pressure on economic activity may be exacerbated by uncertainty over the country's vaccination rollout, although the risk of reduced activity is skewed toward business sectors that involve extensive face-to-face interaction.

AM Best remains confident that most Japanese life insurers' will be able to maintain at least very strong levels of risk-adjusted capitalisation, in addition to financial leverage ratios that are generally more conservative than their global peers. The amount of excess solvency margin held by most domestic insurance companies is also sizable relative to the value of equities and foreign bond holdings, which suggests that there is a significant amount of excess capital available to cushion against market volatility. The major threat to Japan life insurers' prospective economic solvency ratios continues to be the possibility of a steep reduction in domestic interest rates, especially excessive declines in super long dated bond yields.

To access the full copy of this market segment report, please visit http://www3.ambest.com/bestweek/purchase.asp?record_code=310101.

AM Best is a global credit rating agency, news publisher and data analytics provider specialising in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com.

Copyright © 2021 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED.


These press releases may also interest you

at 19:59
Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter of 2024. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with...

at 17:50
The First Bancshares, Inc. ("FBMS" or "the Company") , holding company for The First Bank, (www.thefirstbank.com) reported today financial results for the quarter ended March 31, 2024. Highlights for the Quarter: Net income available to common...

at 17:30
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in thedevelopment oftherapeutics for age-related...

at 17:10
Teradyne, Inc. reported revenue of $600 million for the first quarter of 2024 of which $412 million was in Semiconductor...

at 17:00
Alamos Gold Inc. ("Alamos" or the "Company") today reported its financial results for the quarter ended March 31, 2024. "We delivered another strong start to the year across a number of fronts, following a record performance in 2023. Costs...

at 16:57
Ball Corporation's board of directors (the "Board") today declared a cash dividend of 20 cents per share, payable June 17, 2024, to shareholders of record as of June 3, 2024. In addition, the board also approved the repurchase by the company of up...



News published on and distributed by: